---
title: "Zai Lab Ltd. Sponsored ADR (ZLAB.US) Q3 Earnings Conference Call"
description: "Zai Lab Ltd. Sponsored ADR is a biopharmaceutical company that is dedicated to licensing, developing, and commercializing proprietary therapies to address unmet"
locale: "en"
url: "https://longbridge.com/en/lives/4092"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# Zai Lab Ltd. Sponsored ADR (ZLAB.US) Q3 Earnings Conference Call

**Status**: Unknown
**Category**: Earnings Call

## Description

Zai Lab Ltd. Sponsored ADR is a biopharmaceutical company that is dedicated to licensing, developing, and commercializing proprietary therapies to address unmet medical needs. Its product line includes ZL-2306, ZL-2401, FPA144, ETX2514, and ZL-2301. The company was founded in 2014 by Samantha Ying Du and Marietta Wu and is headquartered in Shanghai, China.

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.